Networks of tubular epithelia are important for the transport of liquids and gases throughout the body[@R1]. The hierarchical order of these networks is an important prerequisite for their correct function. Within the vasculature, a rise in metabolic demand of the brain or muscle tissue leads to vasodilation and an increase in blood flow[@R2], [@R3]. In turn, changes in blood flow can influence blood vessel sizes. Previous studies showed that higher flow rates induce an increase in vessel diameter via outward remodelling, while lower shear stress levels lead to a decrease in blood vessel size via inward remodelling[@R4]--[@R9]. Together, these observations supported the theory of a shear stress set point for the endothelium, with inward and outward remodelling ensuring constant shear rates within blood vessels and therefore homeostasis[@R10]--[@R12]. Despite the attractiveness of this concept, Thoma already noted in 1893 that the unrestricted flow-driven increase of blood vessel diameters during embryonic development would ultimately lead to a situation where two massive blood vessels carry all of the systemic flow[@R13]. This phenomenon was later referred to as the shunt problem[@R14]. Arteriovenous malformations (AVMs) are characterized by enlarged direct connections between arteries and veins bypassing an intervening capillary bed, leading to blood flow shunting. Mutations in the transforming growth factor beta (TGF-beta) pathway components *alk1* or *endoglin* (*eng*) are associated with AVM formation in mouse and humans, where they cause hereditary haemorrhagic telangiectasia (HHT)[@R15]. While mutations in zebrafish *alk1* cause AVM formation[@R16], no zebrafish *eng* gene has been identified so far. Earlier work showed that an increase in endothelial cell (EC) numbers within AVMs leads to blood vessel enlargement and flow shunting[@R16]--[@R19]. However, the precise temporal events of AVM formation and the functions of *alk1* and *eng* in integrating haemodynamic cues with different tube sizes remain poorly understood.

Adult zebrafish *eng* mutants display vascular malformations {#S1}
============================================================

To investigate the mechanisms controlling blood vessel diameters we set out to identify and functionally characterize the zebrafish homologue of *ENG*. Since database searches failed in identifying zebrafish *eng*, we employed a synteny-based approach ([Supplementary Fig.1a](#SD1){ref-type="supplementary-material"}; see [Materials and Methods](#S8){ref-type="sec"}). Sequence analysis of the identified gene predicted a protein product of similar length to human *ENG* ([Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}). In addition, phylogenetic analysis of the cytoplasmic domain placed this gene within the endoglin clade ([Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}). Together with a recent report[@R20], our analysis also suggests that a previously described zebrafish *eng* gene[@R21] more likely belongs to the TGF-beta receptor type 3 (betaglycan) gene family. *In situ* hybridization to detect *eng* mRNA in developing zebrafish embryos revealed vascular-restricted expression ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}), similar to *eng* expression in mouse[@R22] and humans[@R23]. In addition, blocking blood flow reduced *eng* expression within a subset of ECs (cells of the dorsal longitudinal anastomotic vessel (DLAV; [Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}). A similar regulation of endoglin expression via blood flow had been previously reported in mouse[@R24]. Therefore, protein structure, vascular-restricted expression and regulation via shear stress suggest that we identified a zebrafish *ENG* homologue.

We then employed transcription activator-like effector nuclease (TALEN) mediated mutagenesis to disrupt *eng* function. We generated 3 different mutant alleles, two of which led to a frameshift after 15 amino acids (aa) and premature stop codons after 61 aa ([Fig. 1a](#F1){ref-type="fig"}). Expression of *eng* mRNA containing frameshift mutations (*mu130* allele) was reduced, as analysed via qPCR ([Supplementary Fig. 2a](#SD2){ref-type="supplementary-material"}) and *in situ* hybridization ([Supplementary Fig. 2b](#SD2){ref-type="supplementary-material"}, arrows), together suggesting that we have likely generated *eng* loss of function alleles. Surprisingly, in contrast to *Eng* homozygous mutant mice, which die during embryogenesis[@R22], homozygous *eng* mutant zebrafish survived into adulthood ([Fig. 1b](#F1){ref-type="fig"}). Closer examination of the brain vasculature revealed the presence of multiple vascular malformations characterized by tortuous and regionally enlarged blood vessels ([Fig. 1c, d](#F1){ref-type="fig"}, yellow arrowheads). Since vascular malformations in HHT are often detected in regions of active angiogenesis[@R15], we decided to investigate blood vessel morphogenesis in a neoangiogenesis setting, the regenerating zebrafish fin[@R25] ([Fig. 1e](#F1){ref-type="fig"}).

Amputation of wildtype fins resulted in the formation of a distally located vascular plexus, which received blood flow from the artery ([Fig. 1f, g](#F1){ref-type="fig"}). Occasionally (3/89 cases), we observed aberrant blood flow patterns in the regenerate with arteries lacking blood flow ([Supplementary Movie 1](#SD10){ref-type="supplementary-material"}). The frequency of these malformations was greatly increased in *eng* homozygous mutants (49/86 cases; [Supplementary Movie 2](#SD11){ref-type="supplementary-material"}). We detected blood pooling in dilated vessels and blood flow patterns that resembled AVMs with arterial flow prematurely draining into veins without irrigating the distally located blood vessel plexus ([Fig. 1h, i](#F1){ref-type="fig"}, ray \#2). Previous studies implicated increases in EC numbers as the cause for blood vessel enlargement in *Eng* mutants[@R16]--[@R19]. We therefore determined vessel calibres and endothelial cell numbers ([Fig. 1j-o](#F1){ref-type="fig"}). These quantifications revealed increases in vessel diameters both in arteries and veins in homozygous *eng* mutants ([Fig. 1l](#F1){ref-type="fig"}). Surprisingly, EC numbers were only increased in mutant veins ([Fig. 1m](#F1){ref-type="fig"}). Endothelial area was increased in both vessels ([Fig. 1n](#F1){ref-type="fig"}), and consequently cell density decreased in mutant arteries but remained constant in veins ([Fig. 1o](#F1){ref-type="fig"}). Together, these results show that zebrafish *eng* mutants present with enlarged blood vessels that can lead to AVM formation, but partly without increases in endothelial cell numbers.

Mutations in *eng* affect embryonic blood vessel calibres {#S2}
=========================================================

In order to examine if similar vascular malformations also occur during embryonic stages, we examined vascular morphologies in the zebrafish trunk, where angiogenic sprouting generates the intersegmental blood vessels (ISVs)[@R26]. At 72 hpf, wildtype embryos had fully established arterial and venous ISVs, connecting the dorsal aorta (DA) with the posterior cardinal vein (PCV; [Fig. 2a](#F2){ref-type="fig"}). Despite normal blood vessel connectivity in *eng^mu130^* mutants, we noted a dramatic reduction in blood flow through ISVs ([Supplementary Movies 3](#SD12){ref-type="supplementary-material"}, [4](#SD13){ref-type="supplementary-material"}). Nearly 50% of mutant ISVs did not carry erythrocytes ([Fig. 2b](#F2){ref-type="fig"}). Angiography revealed that ISVs were properly lumenized ([Fig. 2c](#F2){ref-type="fig"}, arrows). We observed a small but significant dilation of *eng^mu130^* mutant arterial ISVs (aISV), while venous ISV (vISV) diameters were substantially decreased ([Fig. 2d](#F2){ref-type="fig"}). Mutant aISVs contained similar numbers of endothelial cells when compared to wildtype embryos, whereas vISVs contained marginally fewer cells ([Fig. 2e](#F2){ref-type="fig"}). Thus, a reduction in endothelial cell numbers could explain the decrease in vISV diameters, thereby reducing blood flow. We asked whether the reduced blood flow might cause ISV regression in *eng^mu130^* mutants, as low blood flow has been shown to cause blood vessel pruning[@R27], [@R28]. Two weeks after the onset of ISV blood flow (17dpf time point), we observed pruning of about 20% of ISVs in wildtype embryos ([Supplementary Fig. 3a, f](#SD3){ref-type="supplementary-material"}), suggesting that the trunk vasculature remodels during this time frame. In *eng^mu130^* mutant embryos, we did not observe a change in arterial or venous ISVs nor in the amount of ISVs containing red blood cells at this later time point, but twice as many ISVs had remodelled ([Supplementary Fig. 3b-f](#SD3){ref-type="supplementary-material"}). Hence, loss of *eng* function leads to an increase in blood vessel pruning, possibly as a long-term consequence of altered haemodynamics.

Further evaluation of blood vessel morphologies in 72 hpf embryos showed no change in the ratio of arterial to venous ISVs in *eng^mu130^* mutants compared to wildtype ([Supplementary Fig. 4a, b](#SD4){ref-type="supplementary-material"}). However, we observed an increase in the sizes of the DA and PCV in *eng^mu130^* mutants ([Fig. 2a, c](#F2){ref-type="fig"}, arrowheads, f). Both vessels dilated by approximately 30%, without a change in the number of endothelial cells comprising either the DA or PCV ([Fig. 2g](#F2){ref-type="fig"}). Therefore, in *eng^mu130^* mutants, most of the trunk blood flow is shunted through a direct connection between the major artery (DA) and vein (PCV) while bypassing smaller ISVs. This flow pattern might resemble those found in AVMs in more mature vascular beds[@R29]. ISV blood flow could be significantly rescued by transgenic overexpression of EGFP-tagged *eng* in blood vessels ([Supplementary Fig. 4c-f](#SD4){ref-type="supplementary-material"}), suggesting that the observed phenotypes in *eng^mu130^* mutants are likely due to a loss of *eng* function in ECs.

Blood flow patterns adapt to the expansion of the embryonic vasculature {#S3}
=======================================================================

We took advantage of the stereotypic embryonic trunk vasculature to understand the onset of the AVM-like flow phenotype in *eng^mu130^* mutants, and measured blood vessel diameters over time ([Fig. 3a-d](#F3){ref-type="fig"}). In wildtype embryos, DA and PCV diameters increased between 24 hpf (onset of blood flow) and 48 hpf with the artery always showing a smaller diameter compared to the vein ([Fig. 3a, b](#F3){ref-type="fig"}). This increase in vessel diameters is consistent with an increase in cardiac output and blood flow[@R30], [@R31]. At 72 hpf, however, diameters of both the DA and PCV decreased[@R30], while they continued to enlarge in *eng^mu130^* mutants ([Fig. 3c, d](#F3){ref-type="fig"}). Therefore, while wildtype blood vessels display a biphasic response to increases in blood flow, the second part of this response--blood vessel constriction-- is abrogated in *eng^mu130^* mutants, leading to arteriovenous shunt formation ([Fig. 3e-j](#F3){ref-type="fig"}; [Fig. 4a](#F4){ref-type="fig"}). We next measured blood flow parameters within developing blood vessel shunts using particle image velocimetry[@R32]. At 48 hpf, wildtype embryos displayed pulsatile blood flow in the DA with a peak velocity of about 2000 um/s, which is in agreement with previous reports[@R31]. We noted that this pulsatility was transmitted to the venous flow, exemplified by peak PCV velocities immediately following arterial peaks ([Fig. 4b](#F4){ref-type="fig"}, 48 hpf time point, arrow). Thus, due to the topology of the initial embryonic circulatory loop, the DA and PCV blood flow profiles resemble those present in arterial-venous shunts. Of note, after the addition of ISVs at the 72 hpf time point, pulsatility within the DA remained constant, while venous pulsatility was reduced ([Fig. 4c, f, g](#F4){ref-type="fig"}), as observed in more mature vascular beds[@R33]. In addition, maximum velocity was reduced in the PCV, with a similar trend in the DA ([Fig. 4h, i](#F4){ref-type="fig"}). Shear stress was reduced in both the DA and PCV between 48 and 72 hpf ([Fig. 4j, k](#F4){ref-type="fig"}). In *eng^mu130^* embryos, initial flow profiles at 48 hpf resembled those in wildtype embryos with respect to pulsatility and shear stress, while velocity was reduced ([Fig. 4d, f-k](#F4){ref-type="fig"}). However, at the 72 hpf time point, pulsatility was reduced in the DA, and increased within the PCV ([Fig 4e](#F4){ref-type="fig"}, arrow, f, g). Furthermore, maximum velocity and shear stress were increased both in the artery and vein ([Fig. 4h-k](#F4){ref-type="fig"}). Therefore, while wildtype embryos initially display flow profiles that are reminiscent of an arteriovenous shunt, these are rectified after the addition of capillaries via angiogenesis. In *eng^mu130^* mutants this shunt-like flow becomes exacerbated, leading to dramatic alterations of blood flow profiles.

We hypothesized that the high velocities in *eng^mu130^* mutant AVMs may hinder RBC passage through capillaries, and employed holographic optical tweezers (HOT)[@R34] at the DA entrance of aISVs in *eng^mu130^* mutant embryos to slow down RBC movement. This "optical rail" could divert RBCs from the AVM into aISVs ([Fig. 4l](#F4){ref-type="fig"}; [Supplementary Movie 5](#SD14){ref-type="supplementary-material"}). These findings suggest that haemodynamic changes within the primary axial vessels might prevent capillary RBC perfusion. Therefore, the establishment of aberrant arterial-venous flow patterns in *eng^mu130^* mutant embryos might be caused by structural changes that occur within primary vessels after the onset of blood flow and not due to defects in angiogenesis or lumen formation in capillaries.

*Eng* does not affect *klf2a*-mediated shear stress sensing {#S4}
===========================================================

Our observations show that *eng* mutant blood vessels display aberrant responses to an increase in blood flow. Previous studies showed that ECs align in the direction of shear stress[@R35] in a *klf2a*-dependent manner[@R36]. In order to address if shear stress sensing was defective in *eng^mu130^* mutants, we analysed mRNA expression of *klf2a*, which is upregulated in response to shear stress[@R37]. Surprisingly, *klf2a* was more strongly expressed in the PCV in *eng^mu130^* mutant embryos ([Fig. 5a](#F5){ref-type="fig"}), consistent with our finding that shear stress is higher in this vessel. In order to monitor alterations in shear stress within living embryos, we developed a *Tg(klf2a:YFP)^mu107^* line, which displayed endothelial-specific YFP expression in response to shear stress ([Supplementary Fig. 5](#SD5){ref-type="supplementary-material"}). Consistent with a decrease in blood flow, we observed downregulation of YFP expression in ISVs in *eng^mu130^* mutants compared to wildtype embryos ([Fig. 5b](#F5){ref-type="fig"}, arrows, c). There was a trend in mutant embryos toward a decrease in YFP intensity within the DA and an increase in the PCV ([Fig. 5b, d](#F5){ref-type="fig"}). We further knocked down *ENG* in HUVEC cells exposed to shear stress ([Fig. 5e](#F5){ref-type="fig"}) and analysed the expression of *KLF2* ([Fig. 5f](#F5){ref-type="fig"}) and *CXCR4* ([Fig. 5g](#F5){ref-type="fig"}), a gene reported to be downregulated via shear stress[@R38]. We again found no change in the response of control or ENG siRNA transfected ECs to shear stress. Together, these findings suggest that *eng*-deficient ECs do not have a defect in shear stress sensing upstream of *klf2a*, but can even respond to increased shear stress in embryonic blood vessels with an upregulation of *klf2a* expression.

Loss of *eng* function leads to blood vessel enlargement in an EC autonomous manner {#S5}
===================================================================================

We next set out to investigate the cause for the observed DA and PCV dilation. We reasoned that it might be a secondary consequence of vISV constriction, forcing blood flow into the DA and PCV. Alternatively, dilation of the DA and PCV might prevent ISV blood flow, secondarily leading to a decrease in vISV diameters. In order to distinguish between these possibilities, we performed cell transplantation experiments ([Fig. 6a](#F6){ref-type="fig"}), resulting in situations where either an entire ISV was comprised of donor ECs ([Fig. 6b-e](#F6){ref-type="fig"}) or only parts of a given ISV ([Supplementary Fig. 6](#SD6){ref-type="supplementary-material"}). Transplanting wildtype ECs to wildtype embryos resulted in similarly sized ISVs ([Fig. 6c](#F6){ref-type="fig"}). By contrast, ISVs entirely comprised of *eng^mu130^* mutant endothelial cells in an otherwise wildtype vasculature exhibited an almost 80% increase in diameter ([Fig. 6d, f](#F6){ref-type="fig"}). We observed a similar increase in diameter when we analysed mosaic ISVs ([Supplementary Fig. 6b, e, g](#SD6){ref-type="supplementary-material"}). Transplanting wildtype cells into mutant embryos resulted in a dramatic decrease in lumen diameter in wildtype ISVs ([Fig. 6e, f](#F6){ref-type="fig"}), while mosaic blood vessels showed an intermediate diameter ([Supplementary Fig. 6c, f](#SD6){ref-type="supplementary-material"}). Together, our transplantation experiments suggest that eng acts in a cell autonomous manner within single ECs and that dilation is a primary consequence of loss of eng function.

*Eng* function is necessary for blood flow-induced cell shape changes {#S6}
=====================================================================

We reasoned that changes in EC shapes and not numbers might lead to the observed alterations in tube dimension. In order to address this question, we stained 72 hpf wildtype and mutant embryos for the tight junction protein ZO-1 ([Fig. 7a](#F7){ref-type="fig"}). Endothelial cells in wildtype embryos at 72 hpf showed elongated ECs that were arranged in an orderly, cobblestone-like fashion. In contrast, ECs in *eng^mu130^* embryos showed a disordered DA assembly, with apparently larger ECs. In order to visualize the architecture of ECs in living fish, we utilized a *Tg(fli1a:lifeactEGFP)^mu240^* line together with *Tg(-0.8flt1:RFP)^hu5333^* and *Tg(fli1a:nEGFP)^y7^*. Lifeact-EGFP has been shown to be enriched at cell-cell contacts[@R39], while we observed mosaic expression of *Tg(-0.8flt1:RFP)^hu5333^* in the axial vasculature. In combination, these lines enabled us to distinguish single ECs and quantify their morphologies ([Fig. 7b-g](#F7){ref-type="fig"}). In 48 hpf wildtype embryos, ECs within the DA showed a rounded morphology ([Fig. 7d](#F7){ref-type="fig"}) and were moderately aligned in the direction of blood flow, as measured by the cell angle in relation to the blood vessel ([Fig. 7e](#F7){ref-type="fig"}). At 72 hpf, wildtype cells were more elongated and aligned, while keeping their surface areas and perimeters constant ([Fig 7d-g](#F7){ref-type="fig"}). In effect, these cell shape changes within a tube would lead to a more narrow and elongated tube, as also evidenced by time-lapse imaging ([Supplementary Movie 6](#SD15){ref-type="supplementary-material"}). Therefore, our results show that endothelial cell shape changes between 48 and 72 hpf cause a decrease in DA diameter in wildtype embryos.

The morphology of *eng^mu130^* mutant ECs did not differ from wildtype ECs at 48 hpf, except for a reduction in surface area ([Fig. 7d-g](#F7){ref-type="fig"}). However, at 72 hpf we observed a drastic increase in surface area of about 30% ([Fig. 7f](#F7){ref-type="fig"}). Mutant ECs elongated to the same extent as wildtype cells ([Fig. 7d](#F7){ref-type="fig"}). They also became more aligned to flow over time, but not as well as wildtype cells ([Fig. 7e](#F7){ref-type="fig"}), jointly leading to a less efficient decrease in tube diameter ([Supplementary Movie 7](#SD16){ref-type="supplementary-material"}). These morphometric characteristics are summarized in [Fig. 7h](#F7){ref-type="fig"}. Together, our results show that the increase in blood vessel diameters in *eng^mu130^* mutants is caused by an increase in EC surface areas and aberrant changes in EC shapes.

Due to the reported function of blood flow during AVM development[@R40], we inferred that haemodynamic cues might induce the observed structural changes within ECs. To address this question, we treated zebrafish embryos with 2.25x tricaine from 48-72 hpf in order to reduce cardiac output[@R31]. Tricaine treatment caused a general decrease in EC cell surface areas in both wildtype and *eng^mu130^* mutants, but with a stronger effect in *eng^mu130^* mutant embryos ([Fig. 7f](#F7){ref-type="fig"}). Tricaine also eliminated differences in perimeter and angle of ECs between WT and *eng^mu130^* mutants ([Fig. 7e, g](#F7){ref-type="fig"}). Therefore, blood flow critically influences EC sizes with *eng^mu130^* mutant ECs showing defects in the response to this biophysical stimulus. We then asked if similar *eng* dependent changes in cell size occur in mammalian ECs. We analysed human umbilical vein endothelial cells (HUVEC) in culture and observed EC alignment in the direction of flow as previously published[@R35]. Surprisingly, neither alignment nor EC area were affected by loss of *Eng* ([Fig. 8a-c](#F8){ref-type="fig"}). However, when we analysed EC areas within the aorta of postnatal day 9 mice, we consistently measured an increase in EC areas of about 10% after 4 days of *Eng* deletion ([Fig. 8d, e](#F8){ref-type="fig"}). Together, these findings suggest that mammalian ECs also require *Eng* function for restricting EC sizes. They furthermore indicate that exposing ECs to shear stress alone in a culture setting might not influence EC sizes in the same way as a combination of stretch, shear, and pressure on matrix-adhered ECs in a tube *in vivo* does.

Our results lead to a model in which two distinct EC responses to a rise in blood flow control proper blood vessel geometries ([Supplementary Fig. 7](#SD7){ref-type="supplementary-material"}). Initially, EC areas increase, leading to an expansion of vessel diameters. Subsequently, however, ECs react to the increased flow by limiting area expansion and changing their shapes. They elongate and align in the direction of flow. This, in turn, leads to a decrease in blood vessel diameter, while at the same time allowing for the distribution of blood flow to smaller calibre peripheral vessels. In *eng*-deficient vessels, ECs are unable to limit their surface areas. This impedes their alignment in response to flow and dilates the affected vessel, ultimately exacerbating a pre-existing arteriovenous shunt that severely impairs blood flow to surrounding tissues.

Discussion {#S7}
==========

The assignment of proper calibres to conduits forming tubular networks is instrumental for their correct functioning, and several human disease conditions such as polycystic kidney disease[@R41] or HHT[@R42] are caused by aberrantly sized tubular organs. While we have great insights into the processes governing the formation of a lumen *per se*[@R43], the factors controlling different tube sizes are much less understood. Changes in tube diameters can be achieved either via an increase in the numbers of the cells forming the tube, or by changes in cell shapes[@R44]--[@R47]. While haemodynamics can influence both cellular properties[@R40], [@R48], previous studies showed increased EC numbers within HHT associated AVMs[@R16]--[@R19]. However, while we detected some enlarged blood vessels with supernumerary ECs, we also found enlarged blood vessel segments that did not contain more endothelial cells. In these cases, we found that changes in cell shapes caused blood vessel enlargement. Thus, our studies support an additional process, namely restricting EC sizes in response to blood flow, by which *eng* function determines optimal tube diameters. Possible mechanisms might involve integrin signalling, which can influence cell contractility and shape[@R49], [@R50]. Tzima et al. showed that integrin signalling was necessary for EC alignment to flow[@R51], while a recent study provided evidence that human pathogenic bacteria trigger *eng* expression, thereby activating integrins[@R52].

Thoma already noted that the theory of a shear stress set point is complicated by the shunt problem[@R13]. Our results now provide a possible solution to this problem. The biphasic EC response to blood flow governed by changes in endothelial cell shapes potently counteracts size increases within blood vessels. Previous studies investigating the influence of haemodynamics on vessel sizes artificially changed blood flow in established vascular networks[@R5]--[@R9], [@R53], [@R54]. Our observations suggest that flow rates change dynamically within the forming embryonic vascular system due to the addition of new blood vessel connections, likely creating arteriovenous shunts that need to be corrected. Endothelial cell shape changes might provide a means to adopt tube sizes within quickly changing haemodynamic environments.

At later stages of embryonic development, blood vessels are invested with contractile smooth muscle cells that control vascular tone. Our results show that haemodynamics affect embryonic blood vessel diameters via a direct influence on EC shapes before smooth muscle cell differentiation[@R55]. Importantly, previous studies associated changes in smooth muscle cell coverage with AVM formation[@R22], [@R56]. Therefore, how these two systems of blood vessel size control interact will be of great future interest. Since many tubular organs transport fluid, our results might furthermore describe a general phenomenon how cells lining tubular networks respond to biophysical cues, thereby determining optimal tube diameters.

Methods {#S8}
=======

Zebrafish strains {#S9}
-----------------

Zebrafish were maintained as described previously[@R57]. Transgenic lines and mutants used were *Tg(kdrl:EGFP)^s843^*, *Tg(kdrl:Hsa.HRAS-mCherry)^s916^, Tg(fli1a:nEGFP)^y7^, Tg(fli1a:EGFP)^y1^, Tg(dll4:gal^4FF^)^mu106^, Tg(UAS:GFP)^nkuasgfp1a^*, Tg*(-0.8flt1:RFP)^hu5333^*, *Tg(gata1a:DsRed)^sd2^, Tg(fli1a:lifeactGFP)^mu240^*, Casper *(mitfa^w2/w2^; roy^a9/a9^)*.

References for all zebrafish lines can be obtained on zfin.org. Zebrafish used in this study were between 1-2 years of age and were not selected for gender. All animal experiments were performed in compliance with the relevant laws and institutional guidelines and were approved by local animal ethics committees of the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.

Mice {#S10}
----

*Eng^flox/flox^*:*Cdh5(PAC)CreER^T2^:R26Ryfp* were generated by inter-crosses of the following mice:

*Eng^flox/flox^* [@R58], *Cdh5(PAC)-CreER^T2^* [@R59], and R26Ryfp (also denoted Ai3 in short or alternatively B6.Cg-*Gt(ROSA)26Sor^tm3(CAG-EYFP)Hze^*/J (Stock Number 007903, The Jackson Laboratory). Animal housing and procedures were in accordance with Swedish legislation and approved by the local animal ethics committees.

Identification of zebrafish *endoglin* homologue {#S11}
------------------------------------------------

Identification of Eng and Tgfbr3 orthologs in zebrafish was performed based on homology searches to the most conserved C-terminal cytoplasmic domain, encoded in the 2 last coding exons of the respective human genes. Synteny was identified based on Ensembl. The following proteins were identified:

*Mus musculus* (Mouse) Eng: ENSMUSP00000009705

*Mus musculus* Tgfbr3: ENSMUSP00000031224

*Monodelphis domestica* (Opossum) Eng: ENSMODP00000006956

*Taeniopygia guttata* (Zebra Finch) Eng: ENSTGUP00000003672

*Taeniopygia guttata* Tgfbr3: ENSTGUP00000006307

*Homo sapiens* (Human) Eng: ENSP00000341917

*Homo sapiens* Tgfbr3: ENSP00000212355

*Gallus gallus* Tgfbr3: ENSGALP00000032713

*Anolis carolinensis* Tgfbr3: ENSACAP00000001391

*Xenopus tropicalis* Tgfbr3: ENSXETP00000049788

*Danio rerio* (Zebrafish) Tgfbr3: ENSDARP00000133083

*Gasterosteus aculeatus* (Stickleback) Eng: ENSGACP00000021916

*Gasterosteus aculeatus* Tgfbr3: ENSGACP00000005710

*Takifugu rubripes* (Fugu) Tgfbr3: ENSTRUP00000032677

*Oryzias latipes* (Medaka) Eng: ENSORLP00000008428

*Oryzias latipes* Tgfbr3: ENSORLP00000017470

In addition, genomic sequence encoding syntenic homologous sequences were identified for:

*Xenopus tropicalis* Eng: JGI4.2: GL172790.1:2077326-2079133

*Fugu rubripes* Eng: FUGU 4.0 scaffold_44:587239-594140

*Danio rerio* Eng: GRCz10: Chromosome 5:70875139-70877042

The respective protein sequences were predicted using GenomeScan with the C-terminus of human ENG as a template. Phylogenetic analysis was performed using MEGA7. Multiple sequence alignment was performed using ClustalW, and a phylogenetic tree was generated using the neighbor-joining method.

Generation of zebrafish *eng* mutants {#S12}
-------------------------------------

*eng* mutants were generated by TALEN mutagenesis. TALENs specific to *eng* were designed using the online TAL Effector Nucleotide Targeter (<https://talent.cac.cornell.edu/>) with the 1^st^ exon provided as target sequence. Criteria for optimal TALEN pairs was followed as described in Cermak et al. 2011. The following TALEN pair was selected for optimal length and presence of an MspI site in the spacer, facilitating identification of mutations by PCR and digest.

[5' TALEN arm]{.ul}

DNA sequence: 5'-tgctgtgtttgcttct-3'

RVD sequence: NN HD NG NN NG NN NG NG NG NN NI HD NG NG HD NG

[3' TALEN arm]{.ul}

DNA sequence: 5'-tggagctcttacctga-3'

RVD sequence: NN NN NI NN HD NG HD NG NG NI HD HD NG NN NI

RVDs were assembled using the Golden Gate TALEN kit v2.0 (Addgene), into pTAL4 vectors

Genotyping {#S13}
----------

To detect TALEN activity and later identify genomic lesions, primers End_TAL6 FWD (5'- tcttgcagccctaatcagc-3') and End_TAL6 REV (5'-agcaactgtaaaattaccacaaca-3') were used to amplify a 418 bp fragment spanning the TALEN binding site and spacer region. After MspI digestion, WT amplicons cleave to 246 bp + 172 bp fragments. DNA amplified from the *eng^mu130^* allele does not digest.

Generation of transgenic lines {#S14}
------------------------------

The *Tg(fli1a:eng-GFP)^mu156^* construct was generated via Gateway cloning (Invitrogen). Primers Eng attB1 (5'GGGGACAAGTTTGTACAAAAAAGCAGGCTcca ccatgaagagcatctgctgtgtttt-3') and Eng NOS attB2 (5'-GGGGACCACTTTGTACAAGAA AGCTGGGTatgccatgct gctggtgggtg-3') were used to amplify the full-length zebrafish endoglin ORF from an EST obtained from Open Biosystems (EDR4422-98253197). This fragment was cloned into the Gateway entry vector pDONR221 via standard BP reaction to generate Dr eng NO STOP pDONR221. For vascular-specific expression and visualization of protein localization, we performed LR reaction with Dr eng NO STOP pDONR221, p5EntryFli1ep and p3Eegfp into the pDestTol2aspA destination vector[@R61]. Plasmid DNA was isolated by Midiprep (Qiagen) and injected into *eng^mu130^* homozygous mutant embryos at \~25pg/embryo together with \~50pg *tol2* transposase mRNA[@R62].

To generate the Tg(*klf2a:YFP*)^*mu107*^ line, BAC recombineering was employed as previously described[@R62]. BAC clone CH73-180A21 (obtained from Children\'s Hospital Oakland Research Institute) containing the entire *klf2a* gene was modified by addition of iTol2 sites and insertion of a Citrine cassette at the ATG of *klf2a*.

### klf2a:YFP intensity measurements {#S15}

Embryos were crossed in such a way as to ensure that only 1 copy of *Tg(kdrl:Hsa.HRAS-mCherry)^s916^* and *Tg(klf2a:YFP)^mu107^* were present. Experiments were performed 3 times and imaged on the same microscope with the same settings for the same time points (but not between time points). Imaris was used to crop away epidermis and the far side of the embryo as much as possible. ImageJ was used to calculate average pixel intensities on maximum intensity projections using the mCherry channel to outline vessels of interest.

Immunohistochemistry and whole-mount *in situ* hybridization {#S16}
------------------------------------------------------------

The *klf2a* probe was described previously[@R37]. The *endoglin* ISH probe was generated from the aforementioned EST from Open Biosystems (EDR4422-98253197). In brief, the plasmid was linearized with SalI and IVT reaction performed with Sp6 polymerase for antisense probe synthesis. Whole-mount *in situ* hybridization of zebrafish embryos was performed as described[@R37]. For visualization of tight junctions, we performed immunostaining with mouse monoclonal anti-Human ZO1 antibody (Invitrogen 339100). Embryos were fixed in 2% PFA/PBSTween (0.3%) overnight at 4°C. Embryos were washed 4x5 min in PBSTween (0.3%), then permeabilized in 100% acetone for 5 min at -20°C. Embryos were then given 2 quick washes, followed by 3x 5 min and 1 x 15 min in PBSTx (0.3% Tween20, 0.6% TritonX-100.). They were further permeabilized for 5 min with 10 ug/uL Proteinase-K in PBSTx (0.3% Tween 20, 0.6% TritonX-100). Digestion was stopped with 4% PFA for 20 min at room temperature. Embryos were blocked for 2 hrs in blocking solution (0.6% TritonX-100, 10% normal goat serum, 1% BSA, 0.01% sodium azide in PBSTween (0.3%)). Primary antibody was diluted 1:200 in blocking solution on 4°C shaker overnight. The following day, embryos were washed 6 x 1 hr in PBSTween (0.3%). Embryos were incubated in AlexaFluor goat anti-mouse 546 secondary antibody (Invitrogen A11003) diluted 1:1000 in PBSTween (0.3%) overnight on 4°C shaker. Embryos were washed at least 6 x 1 hr in PBSTween (0.3%) prior to imaging. All experiments were performed at least 3 times (with the exception of the *eng* ISH in *eng^mu132^* embryos, this was performed 2 times).

### *eng* nonsense-mediated decay {#S17}

Stainings were done on embryos obtained from heterozygous incrosses. All WT and *eng^mu132^* embryos had a characteristic "dark" staining pattern, while embryos from *eng^mu130^* +/- incrosses had clearly "dark," "medium" and "light" staining patterns. All embryos were imaged and genotyped.

"n/n" reports "number of embryos with staining pattern in image"/"total embryos from 3 experiments"

In *eng^mu130^* +/- incross embryos, +/+, +/- and -/- genotypes invariably correlated with "dark," "medium" and "light" staining patterns.

### *klf2a in situ* hybridization {#S18}

Stainings were done on embryos obtained from heterozygous incrosses. Embryos were pre-sorted based on "light" staining in axial vessels in trunk or "dark" staining particularly in PCV, and then genotyped.

"n/n" reports "number of embryos with indicated genotype"/"total \# of embryos of that genotype in 3 experiments that had pre-sorted staining pattern as in picture" WTs and heterozygous embryos were indistinguishable with "light" trunk expression, while most *eng^mu130^* mutants had clearly enhanced staining in PCV.

Live Imaging and Microscopy {#S19}
---------------------------

Embryos were mounted in 1% low melting point agarose in E3 medium supplemented with 168 mg/L Tricaine (1x) and 0.003% phenylthiourea (to prevent pigment formation) for all live imaging experiments. Confocal z-stacks were acquired on inverted SP5 (Leica Microsystems) and LSM780 (Zeiss) scanning confocal microscopes. For 24 h time-lapses and blood flow measurements, stage incubation was used to maintain constant temperature of 28.5°C.

Morpholino Injections, Microangiography and Drug treatments {#S20}
-----------------------------------------------------------

Morpholinos were obtained from Gene Tools, resuspended in distilled H~2~O and around 2 nL injected into 1 cell stage embryos to deliver the following doses: standard control MO 5'-CCTCTTACCTCAGTTACAATTTATA-3' (4 ng/embryo) *tnnt2a* MO 5'- CATGTTTGCTCTGATCTGACACGCA-3' (4 ng/embryo) Microangiography was performed as described[@R28] using Qdots 633 nm (Life Technologies). For nifedipine treatments, nifedipine (Sigma-Aldrich) was dissolved in DMSO to 10 mM stock concentration, and diluted in E3 medium to 15 uM (together with final conc. 2x tricaine). Embryos were treated from 48-52 hpf and fixed in 4% PFA overnight at 4°C.

Genetic ablation of Eng in mouse aorta {#S21}
--------------------------------------

Mice were injected with 50 ug tamoxifen at P4 and sacrificed at P9. Both males and females were included in the analysis. Thoracic aortae were excised and fixed in 4% PFA for 2 hours at RT. Whole mount staining was performed with antibodies against CD31, GFP and ERG1 and samples were flat mounted and imaged using a SP8 Leica microscope.

Antibodies: goat anti-mouse CD31 (AF3628, R&D Systems 1:500); rabbit anti-ERG (Clone: EPR3864, ab92513, Abcam, 1:500); chicken anti-GFP (ab13970, Abcam, 1:1000);

Secondary antibodies used were: Donkey anti-goat IgG Cy3 (705-166-147, JacksonImmunoResearch, 1:400), Donkey anti-chicken IgY (IgG) Alexa488 (703-545-155, JacksonImmunoResearch, 1:400), Donkey anti-rabbit IgG Alexa647 (A31573, Life technologies, 1:500).

Blastomere transplantations {#S22}
---------------------------

Cell transplantations were performed as described previously[@R63]. All experiments were performed at least 3 times. For aISV diameter calculations, around 6-10 measurements were taken in each of 4 quadrants along the aISV (2 below the horizontal myoseptum and 2 above). From the measurements, averages were taken for each of 3 possible categories (Donor only, Host only, mosaic) in each quadrant. For final tabulation, each ISV contributed data points from each quadrant, with a maximum possibility of 3 values per quadrant (depending on composition). This is important, as we measured a significant increase in diameter of normal WT aISVs as they travel from the DA to DLAV, and therefore the effect of donor cell incorporation must also reflect where in the vessel they reside.

Fin Regeneration Experiments {#S23}
----------------------------

Fin amputations were performed as previously described[@R25].

Morphology of adult brain blood vessels {#S24}
---------------------------------------

To characterize morphology of the brain vasculature, adult zebrafish were sacrificed and freshly dissected brains were imaged immediately on a stereomicroscope. Images shown in [Figure 1](#F1){ref-type="fig"} are representative of results obtained in 5 WTs and 5 mutants from 3 independent experiments.

ISV remodelling {#S25}
---------------

To examine ISVs in juvenile zebrafish, embryos were obtained from incrosses of Casper +/-; *eng^mu130^* +/- parents. Fish were sorted for the Casper phenotype (lack of pigmentation) and *eng^mu130^* mutants and siblings (+/+ and +/-) were separated and entered into the fish system. Imaging of the trunk ISVs over the yolk extension was done at 17 dpf.

20x images were made of ISVs over the yolk extension in 17 dpf juveniles expressing the *Tg(kdrl:EGFP)^s843^* and *Tg(gata1a:DsRed)^sd2^* trangenes. This corresponded to \~10-12 ISVs per fish. Fish were excluded if they had not developed prominent intercostal vessels by this time, indicative of developmental delay. Analysis was performed on 3 separate clutches. aISVs and vISVs were quantified based on morphology (connection to DA or PCV). A remodelling event was defined as an ISV that no longer made a connection to the DLAV or DA/PCV. RBC perfusion was defined as the presence of a DsRed+ erythrocyte in the lumen anywhere along the length of the ISV.

Optical Rail {#S26}
------------

Optical rail experiments in zebrafish were done in 72 hpf zebrafish embryos inside an Okolab tabletop incubator at 28.5°C. Fish embryos were mounted in WillCo Wells 100 um thick glass bottom dishes. A 1064 nm 3W cw Cobolt Rumba laser was used for trapping. A Hamamatsu X10468-13 spatial light modulator was used together with Red Tweezers[@R20] to holographically modulate the beam for rough positioning of the laser beam on the capillary entrance. A CFI P-Apo IR 60x WI/ 1.27/ 0.17 objective from Nikon was used to focus the laser into the sample plane of a Nikon Ti-E 2000 microscope. A shutter from Thorlabs was used to block the laser beam before the microscope during "off" periods of the measurement. The motorized stage of the microscope was used for fine positioning of the sample with regard to the laser. An IDS Germany GmbH uEye337x-CP camera was used for movie acquisition during experiments. Movies were taken for 30 s without the laser, 30 s with the laser and 30 s without the laser consecutively. The laser was blocked by the shutter during periods without the laser.

Flow Parameter Analysis {#S27}
-----------------------

High-speed movies of zebrafish embryos were acquired of embryos inside the Okolab heating chamber at 28.5°C. Fish were kept at rest for 5 minutes inside this chamber prior to movie acquisition. Further fish were kept inside an Eppendorf Galaxy 48 S. Fluorescence movies were taken with the IDT NX8-S2 camera at 30 frames per second for 33 s. High-speed brightfield movies were acquired with the same camera at 2000 frames per second with maximum number of frames possible. Due to the limited memory of the NX8 S2 only 5000 to 6000 frames could be acquired leading to a measurement of roughly 10 heartbeat cycles. The region of interest was chosen to acquire both DA and PCV above the yolk extension right before the anal pore. Camera angle was chosen such that the blood flow was going along x or horizontal direction of the movies. Flow movies were analyzed with MPIV (Matlab Particle Image Velocimetry)[@R64] to obtain velocity values of RBCs over time. To improve contrast, a background correction was done by averaging over 50 frames evenly distributed over the whole movie and subtracting this averaged frame from the evaluated frames. These frames show only RBCs and no more background. Fluorescence images were meaned along the whole fluorescence movie to average over the size of the vessel during dilation and constriction. The image was merged with a normal brightfield frame as a reference of where RBCs were flowing. Vessel walls were then manually outlined. Flow velocity profiles were averaged over 5 consecutive frames to minimize velocity noise. Velocity profiles along the cross-section of the vessel were fitted with a parabolic function. For testing, linear flow profiles were fitted, but quality-of-fit investigations, especially R-squared values, showed a better fit of the parabolic fit as did Jamison et al. 2013[@R32] and in contrast to Hove et al. 2003[@R65]. Due to the size of the region of interest in the movie and the quality of the PIV results, 10-14 such cross-sections per fish could be evaluated leading to an equal number of parabolic curves for DA and PCV for each time point obtained. Through these, shear-rate-over-time graphs were calculated and extremal points were averaged over all frames and all positions along the vessels measured to yield one value per fish ([Fig. 2 f-k](#F2){ref-type="fig"}). Shear stress was calculated by $\sigma = \eta\frac{dv}{dy}$ were η is the viscoelasticity of the medium, i.e., the blood, and $\frac{dv}{dy}$ is the derivative of the parabolic fit along the vessel evaluated at the vessel walls. The viscoelasticity of the medium was assumed to be purely viscous, i.e. real in values, and to be 5 times the value of water at the respective temperature according to Anton et al. 2013[@R66]. We have to clarify that an accurate determination of in vivo shear rate would include a proper investigation of the viscoelastic nature of the blood in vivo and taking into account other effects, such as the Fahraeus Lindqvist effect by Fahraeus et al. 1931[@R67]. Pulsatility index values were calculated from extremal velocity flow profiles[@R68]. Values between WT and *eng^mu130^* fish were compared by Mann-Whitney U Test due to unknown distribution of points. Evaluation was performed with custom-written Matlab codes (The MathWorks GmbH).

### Capillary red blood cell flow {#S28}

Presence of RBC flow and direction of flow was scored along every position of the trunk on both sides of the embryo. Data are presented as the percentage of total ISVs scored at every position that had active RBC passage. For images of 30, 48 and 72 hpf embryos with the *Tg(gata1a:DsRed)^sd2^* transgene, surfaces were used in Imaris to generate masks around the *Tg(kdrl:EGFP)^s843^* channel to remove DsRed fluorescence from neurons, hypochord and other non-erythrocyte sources.

### Flow block experiments {#S29}

"n/n" reports "number of embryos with staining pattern in image"/"total embryos from 3 experiments"

Cell culture experiments {#S30}
------------------------

HUVEC (Invitrogen) were cultured in M200 medium supplemented with LSGS (Invitrogen) and used until passage 4. The cells were transfected with 20 nM Silencer Select Pre-designed siRNA (Ambion): ENG-si1 (s4677): 5'-UGACCUGUCUGGUUGCACAtt-3'ENG-si2 (s4678): 5'-GGACUGUCUUCAUGCGCUUtt-3'Silencer Select Negative Control \#1 siRNA

using Oligofectamine and used for flow experiments 48 h after transfection. Down-regulation was confirmed with qPCR and western blot using anti-ENG antibody (\#14606, Cell Signaling, dilution 1:1000) and anti-tubulin antibody (T6199, Sigma, dilution 1:4000) as loading control. HUVEC were seeded at the density 5×10^4^ cells/cm^2^ in μ-Slide^0.4^ Luer (ibidi) and allowed to attach for 3 h. Afterwards the cells were exposed to shear stress of 15 dyn/cm^2^ for 4 h (for qPCR) using the ibidi Pump System. For alignment experiments HUVEC were exposed to shear stress of 15 dyn/cm^2^ for 24 h starting with 5 dyn/cm^2^ and 10 dyn/cm^2^ for 1 h each. Afterwards cells were fixed with 4% PFA and permeabilized with 1% Triton X-100. VE-cadherin was visualized with anti-VE-cadherin antibody (\#55561, BD, dilution 1:200) together with anti-mouse Alexa Fluor 546 secondary antibody (A11003, Invitrogen, dilution 1:200), and nuclei were stained with Hoechst 33342 (1 ug/ml). Five random images were taken for quantification with Leica SP5 microscope at 20x magnification. Angle of the nuclei to the direction of flow was measured with ImageJ. No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated. The cell lines were not tested for mycoplasma contamination.

FACS sorting of ECs from zebrafish embryos {#S31}
------------------------------------------

Arterial and venous ECs were obtained from pooled triple-transgenic 72 hpf zebrafish embryos. *Tg(kdrl:Hsa.HRAS-mCherry)^s916^* exhibits pan-endothelial expression, and the combination of *Tg(dll4:gal4)^mu106^*; *(UAS:GFP)^nkuasgfp1a^* labels the arterial ECs within this population. Embryos were deyolked in calcium free Ringer's solution and treated with 0.5% Trypsin-EDTA (Gibco, 15400-054) plus 50 mg/ml collagenase Type IV (Gibco,17104-019) and dissociated by constant pipetting. The reaction was stopped by adding 5% FBS and the cells were pelleted by centrifuging at 350 g for 5 min at 4°C. The pelleted cells were washed twice with 1x HBSS buffer (Gibco, 14185052) and passed through 40-micron nylon filters. Fluorescent activated cell sorting (FACS) was performed on the cell suspension for arterial (Cherry+/GFP+) and the venous (Cherry+) cells at room temperature. The sorted cells were collected in RLT buffer for RNA isolation.

qPCR experiments {#S32}
----------------

RNA was isolated using RNeasy Micro Kit (Qiagen) and cDNA was produced with iScript cDNA Synthesis Kit (BioRad). qPCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems). Relative expression was calculated with qBase software using RPL13A (HUVEC) or *rpl13a* (zebrafish) as endogenous control. Statistical analysis was performed using CNRQ values from qBase.

1.  [Human qPCR primers:]{.ul}

2.  ENG-fwd: 5'-TGCTCATGTCCTTGATCCAG-3'

3.  ENG-rev: 5'-CTTCAAATGCGCAACAAGC-3'

4.  KLF2-fwd: 5'-CTTCTCTCCCACCGGGTCTA-3'

5.  KLF2-rev: 5'-TAGCCCAAAAATGCCCACCT-3'

6.  CXCR4-fwd: 5'-GCCCTCCTGCTGACTATTCC-3'

7.  CXCR4-rev: 5'-GGCAGGATAAGGCCAACCAT-3'

8.  RPL13A-fwd: 5'-TCGTACGCTGTGAAGGCATC-3'

9.  RPL13A-rev: 5'-CAGCATACCTCGCACGGTC-3'

```{=html}
<!-- -->
```
1.  [Zebrafish qPCR primers:]{.ul}

2.  rpl13a-fwd: 5'-TCTGGAGGACTGTAAGAGGTATGC-3'

3.  rpl13a-rev: 5'-AGACGCACAATCTTGAGAAGCAG-3'

4.  eng-fwd: 5'-GCCGGAGATCCACAGCTTCAGA-3'

5.  eng-rev: 5'-GTTATCGAAAAGCATGGCGTGGC-3'

Blood vessel diameter, cell number and cell shape analysis {#S33}
----------------------------------------------------------

For DA and PCV diameter calculations (72 hpf embryos), measurements were taken at the midway point between ISVs along the yolk extension (ISVs \#5-14), and the mean used as an average diameter/embryo. Similarly, nuclei counts were obtained for the axial vessels over the yolk extension (between ISVs \#5-14). For ISV diameter, 4 measurements were made along each ISV between the DA and the DLAV and averaged to obtain an average ISV diameter. Nuclei were also counted in each ISV. Reported values come from ISVs \#5-14 that had RBC flow.

To obtain diameter and nuclei measurements in regenerating fins at 5dpa, blood flow movies were examined to identify AVMs in *eng^mu130^* mutants. For each mutant, a WT fin was chosen simultaneously for pairwise analysis based on similar blood flow and vascular outgrowth at the location of the AVM in the mutant. ImageJ was used to trace a 200 um length of artery beneath the AVM, and \~15-20 equally spaced diameter measurements were used to obtain an average diameter. ECs residing in this 200 um of vessel were also counted. Diameter and EC number were measured the same way in the vein downstream of the AVM. In the accompanying WT, 200 um of artery in a similar region and the larger of the two paired veins was analyzed in the same way.

For cell shape analysis in zebrafish, images were taken with a 40x water objective of the DA just posterior to the anal pore (small working distance meant this location was easier to image than more anterior over the yolk extension). 2 WT and 2 mutant fish with similar total DA cell numbers were selected and cell shapes were analyzed as described above. For analysis of EC size in mouse aorta preparations, the outlines of the aortic ECs were identified by CD31 staining. The area of each EC was measured in Volocity.

In order to analyze cell shapes in zebrafish embryos, apical cell outlines were traced manually using Imaris. About 100 measurement points were generated per cell on average. These points were then unrolled onto a two dimensional surface as follows: First, an axis was fitted through the center of the blood vessel in such a way that the measurement points lie as close to one curve as possible, when projected on a surface perpendicular to the axis. This was done by varying orientation and position of the axis and minimizing the variation in distance from the axis to measurement points that were grouped according to angle with respect to the axis. Manual markings of the start and the end of the blood vessel were used as starting point and minimization was performed using the steepest descent method. Then an ellipse was fitted through the measurement points as projected on the surface perpendicular to the fitted axis. Fitting was performed using the fit_ellipse function by O. Gal from the MathWorks depository, which uses a least squares criterion. Some of the cells could not be fitted in this way, since the shape of the projected curves resembles a hyperbola instead of an ellipse. In these cases a hyperbola was fitted and subsequent analysis was performed in an analogous way. The hyperbola was fitted using the EllipseFitByTaubin by N. Chernov from the MathWorks depository, which is based on an algorithm developed by G. Taubin[@R69]. About 3% of all cells were fitted to both branches of a hyperbola, which impeded further analysis, so that these measurements were left out.

For some cells, the fit to the ellipse was not good enough to obtain reliable results. As measure for the quality of the fit we took the standard deviation of the residuals of the points on the curve and the points projected on the ellipse, relative to the distance of the projected point to the center of the ellipse (S): $$S = \sqrt{\frac{1}{\left( {n + 1} \right)} \ast \sum_{n}\left( \frac{d_{1}}{d_{2}} \right)^{2}}$$ , where n is the number of points on the curve, d~1~ is the distance between the point on the curve and the same point projected on the fitted ellipse, and d~2~ is the distance of the projected point to the center of the fitted ellipse. Cells with a value of S higher than 0.1 were discarded for analysis, which corresponds to 18% of the unrolled cells. Changing this threshold to 0.13 only had minor effects on p-values obtained. In that case, 11% of the unrolled cells were discarded. The fits on the hyperbola were all good enough for further analysis.

Upon fitting the ellipse or the hyperbola, measurement points were projected onto it. For the hyperbola the Residuals_hyperbola function by H. Ma from the MathWorks depository was used, which is an adaptation of an algorithm introduced by D. H. Eberly[@R70]. The ellipse or hyperbola was then unrolled, resulting in a two-dimensional cell shape. As a control for the procedure, the perimeter was calculated from this two-dimensional projection, as well as from the original measurement points by assuming straight lines between the points for the latter case. The mean difference between these values was 1.7%, thus providing validation for the procedure. Cell area was calculated from the two-dimensional projection using a standard equation for calculating polygon areas (<http://mathworld.wolfram.com/PolygonArea.html>), and cell elongation and orientation were obtained using the fit_ellipse function on this projection. Elongation was defined as the ratio of the long axis and the small axis minus 1 and the orientation is the tilting of the long axis.

In order to estimate the error arising from this procedure, the unrolling of the ellipse was also performed in a way to maximize the error: instead of projecting the measurement points on the ellipse and then unrolling this ellipse, the projection was not carried out and unrolling was performed for each point individually, using an ellipse that was resized to go through the measurement point. Analogously, for the hyperbola the major and minor axes were rescaled for each measurement point. For statistical analysis, the analysis error was taken into account by replacing the standard deviation (sd) by the following measure: $$sd\prime = \sqrt{sd^{2} + \frac{1}{\left( {n - 1} \right)} \ast \sum_{n}\left( {a\left\lbrack i \right\rbrack - a\prime\left\lbrack i \right\rbrack} \right)^{2}}$$ , where n is the number of cells that are analyzed, a\[i\] is the calculated value of the i^th^ cell and a'\[i\] is the value that was obtained for the same cell in the alternative way. Significance was determined using a student-t test with the adjusted standard deviation.
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![Zebrafish *eng* mutants develop AVMs.\
**(a)** TALEN target site of zebrafish *eng* and isolated alleles. Endoglin domain structure predicted by zebrafish primary sequence: signal peptide (SP, red), Zona Pellucida domain (ZP, blue), transmembrane region (TM, orange), cytoplasmic region containing a serine/threonine-rich sequence (green) and a C-terminal PDZ-binding motif (yellow star). **(b)** Adult WT and *eng^mu130^* zebrafish. Scale bar is 10 mm. **(c, d)** Dorsal **(c)** and ventral **(d)** images of dissected brains from aged zebrafish. WTs exhibit hierarchical organization of vasculature, with large calibre vessels (arrows in inset). *eng^mu130^* zebrafish present with dilated tortuous vessels (arrowheads in inset) and loss of hierarchical patterning. Images are representative of 5 WT and 5 mut fish. Scale bar is 500 um (overview), 100 um (inset). (**e)** Schematic of fin regeneration model. **(f-i)** Still images from blood flow movies in 5 dpa fin regenerate and cartoon depiction of blood flow (arrows) in WTs **(f, g)** and *eng^mu130^* mutants **(h, i)**. Numbers label individual rays in the movie. Arrows indicate flow direction, arrowheads highlight reversals. Numbers in parentheses depict number of rays in analysed fish sharing a similar flow characteristic (89 rays from 12 WT, and 86 rays from 12 mut). X indicates large inactive vessel. Note bleedings at distal tips of regenerating rays in *eng^mu130^* fish. Scale bar is 200 um. **(j, k)** Maximum intensity projections of confocal z-stacks of AVM in *eng^mu130^* regenerate and comparable region in WT at 5 dpa. Dashed line indicates amputation plane. Solid lines indicate vessel calibre and yellow bracket indicates region of vasculature analysed (inset). Cartoon depicts blood flow patterns in movies. Note shunting of arterial blood to the vein in mutant AVM, and flow reversal in distal part of affected vein (arrowhead). Scale bar is 400 um (overview), 50 um (inset). **(l-p)** Quantification of diameter **(l)**, endothelial cell (EC) number **(m)**, endothelial area **(n)** and cell density **(o)** in arteries and veins in proximity to AVM in *eng^mu130^* fish and comparable WT regions (n=9 WT, n=9 mut). Analysed by paired Student's *t*-test.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f001){#F1}

![Zebrafish 72 hpf trunk vasculature recapitulates an AVM-like phenotype.\
**(a)** Cartoon of 72 hpf embryo, box indicates region of images. Maximum intensity projection of confocal z-stack of single segmental unit in zebrafish trunk at 72 hpf. *Tg(kdrl:Hsa.HRAS-mcherry)^s916^* labels EC membranes, while *Tg(fli1a:nEGFP)^y7^* shows EC nuclei. The dorsal aorta (DA), posterior cardinal vein (PCV), arterial and venous intersegmental vessels (aISVs and vISVs) are labelled. Blood flow direction indicated with arrows. Scale bar is 60 um. **(b)** Quantification of the number of ISVs actively carrying RBCs shows approximately 50% reduction in *eng^mu130^* embryos (515 ISVs from 9 WT embryos, 686 ISVs from 12 mut embryos). **(c)** Angiography with Qdots 633 nm in *eng^mu130^* sibling and mutant. Both sibling and mutant embryos show lumenization of nearly all ISVs (arrows). Note, however, the dramatic increase in diameter of axial vessels in the mutant compared to sibling (arrowheads). Images are representative of 6 WT and 6 mut embryos. Scale bar is 100 um. **(d)** Quantification of vessel diameter for aISVs and vISVs in WT and *eng^mu130^* mutant embryos. In WTs, vISVs have a larger diameter than aISVs. In mutants, aISVs slightly dilate while vISVs have a reduced calibre (n=38 aISVs/46 vISVs from 9 WTs; n=23 aISVs/43 vISVs from 12 mut). Analysed by unpaired Student's *t*-test. **(e)** Quantification of EC number in ISVs. There is no change in the EC number in aISVs, while vISVs show a slight reduction in EC number. Analysed by Mann-Whitney *U* test (n=38 aISVs/46 vISVs from 9 WTs; n=23 aISVs/43 vISVs from 12 mut). **(f)** Quantification of vessel diameter for the DA and PCV in WT and *eng^mu130^* mutant embryos. Both DA and PCV show significant dilation in mutants (n=9 WT, n=12 mut). Analysed by unpaired Student's *t*-test. **(g)** Quantification of the number of ECs in the DA and PCV. WT and *eng^mu130^* mutants have no difference in EC numbers in these vessels (n=9 WT, n=12 mut). Analysed by unpaired Student's *t*-test.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f002){#F2}

![Analysis of DA and PCV diameter during development.\
**(a, b)** Average DA **(a)** and PCV **(b)** diameter in WT embryos from 24-72 hpf. Notice steady increase in vessel calibre until 48 hpf, followed by reduction at 72 hpf. **(c, d)** Average DA **(c)** and PCV **(d)** diameter in *eng^mu130^* embryos from 24-72 hpf. Same progression of vascular calibre increases as WT until 48 hpf, with pronounced failure to reduce size at 72 hpf in both artery and vein (WT 24, 36, 48, 72 hpf: n=8, 11, 10, and 9 embryos; Mut 24, 36, 48, 72 hpf: n=8, 11, 10, 12 embryos). Analysed by unpaired Student's *t*-test. **(e-j)** Maximum intensity projections of confocal z-stacks of WT **(e-g)** and *eng^mu130^* mutants **(h-j)** at 30, 48 and 72 hpf. Dashed lines indicated DA (red) and PCV (blue), while arrows indicate flow direction. At 30 hpf, the ISV network is still in the process of forming via sprouting angiogenesis, and does not have RBCs in the vessels. In WTs, RBC flow in ISVs is weak at 48 hpf and strongly increased by 72 hpf (yellow arrowheads in **f** and **g**). White arrowheads (**i** and **j**) show ISVs that are lumenized but do not carry RBCs in *eng^mu130^* mutants. Images are representative of 6 WT and 6 mut embryos. Scale bar is 100 um.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f003){#F3}

![Blood flow patterns adapt to the expansion of the embryonic vasculature.\
**(a)** Cartoon depicting blood flow changes through axial vasculature during development. At 24 hpf, all blood flow is through a primary arterial-venous loop. The addition of new capillaries through angiogenesis creates longer loops that are perfused with RBCs in WT, but not in *eng^mu130^* mutants. **(b-e)** Representative DA (red) and PCV (blue) blood flow profiles for sibling and *eng^mu130^* mutant embryos at 48 hpf and 72 hpf. Arrows indicate PCV velocity peaks following arterial velocity peaks. **(f-k)** Quantification of DA and PCV blood flow parameters (pulsatility, maximum velocity and maximum shear stress) in siblings and *eng^mu130^* mutants between 48 hpf and 72 hpf (48 hpf n=21 siblings, n=11 mut; 72 hpf n=10 siblings, n=7 mut). Analysed by Mann-Whitney *U* test. **(l)** Still images from movie showing diversion of RBCs into aISV by application of holographic optical tweezers (HOT). Arrow indicates direction of DA blood flow. aISV outlined by dashed red lines. Red circle denotes HOT laser focal point near aISV entrance. Dashed white circles highlight RBCs in lumen of aISV. Quantifcation of RBC flow through the same ISVs with HOT inactive (laser off) or active (laser on) (n=16 aISVs). Analysed by Mann-Whitney *U* test.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f004){#F4}

![*Eng* does not affect *klf2a-*mediated shear stress-sensing.\
**(a)** Whole-mount *in situ* hybridization of endogenous *klf2a* expression in WT or *eng^mu130^* mutant embryos at 72 hpf. Note enhanced staining in PCV of *eng^mu130^* mutants (arrows). Images are representative of 21 out of 21 WT embryos and 15 out of 20 mut embryos. Scale bar is 100 um. **(b)** Maximum intensity projection of confocal z-stack of zebrafish trunk at 72 hpf. *Tg(klf2a:YFP)^mu107^* exhibits vascular-specific YFP expression, evidenced by overlap with *Tg(kdrl:Hsa.HRAS-mCherry)^s916^*. *eng^mu130^* mutants also display YFP expression in axial vessels, but decreased expression in ISVs (arrows). Scale bar is 100 um. **(c, d)** Quantification of YFP fluorescence intensity in ISVs, DA and PCV of WT and *eng^mu130^* mutants. ISVs have reduced YFP signal, while *eng^mu130^* mutants have a trend toward less intensity in the DA and more intensity in the PCV (not significant) (ISVs n=51 ISVs from 7 WT, n=62 ISVs from 9 mut; DA/PCV n=7 WT, n=9 mut). Analysed by Mann-Whitney *U* test. (**e)** Down-regulation of ENG in HUVEC. siRNA efficiency was confirmed with western blot (representative of 8 blots is shown, molecular weight in kDa is shown on the left). Full size western blots are shown in [Supplementary Fig. 8](#SD8){ref-type="supplementary-material"}. (**f, g)** The expression of shear stress responsive genes KLF2 **(f)** and CXCR4 **(g)** in siRNA-transfected HUVEC exposed to 15 dyn/cm^2^ for 4 h. mRNA expression data are shown as log2 values (mean±SEMs) relative to Neg-si, which was set as 0 (n=3 independent experiments). Statistical analysis was performed with One-Way ANOVA and Tukey's multiple comparison test.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f005){#F5}

![Loss of *eng* function leads to blood vessel enlargement in an EC autonomous manner.\
**(a)** Schematic of transplantation scheme, using GFP-labelled donor cells and mCherry-labelled host cells. Analysis of vasculature was performed at 72 hpf. **(b)** Maximum intensity projection of confocal z-stack of mosaic embryo. Some ISVs can be derived completely from donor cells (note dilation of mutant aISV on left compared to WT aISV on the right). Scale bar is 50 um. **(c-e)** Representative examples of donor-derived ISVs from **(c)** WT-\>WT **(d)** Mut-\>WT and **(e)** WT -\> Mut transplantations. Optical sections of the lumen reveal complete enclosure by donor cells. Scale bar on overview is 50 um, scale bar on lumen cross-section is 10 um. **(f)** Quantification of diameter of donor-derived aISVs. (WT-\>WT n=52 vessel segments from 13 ISVs; Mut-\>WT n=20 vessel segments from 5 ISVs; WT-\>Mut n=24 vessel segments from 6 ISVs). Analysed by One-Way ANOVA.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f006){#F6}

![Endoglin function is necessary for blood flow-induced cell shape changes.\
**(a)** Maximum intensity projection of confocal z-stack of the DA at 72 hpf. ZO-1 labels EC tight junctions, which are present in both WT and *eng^mu130^* mutants. Note the relatively disordered arrangement of mutant ECs compared to WT. Representative of 5 WTs and 5 muts. Scale bar is 50 um. **(b, c)** Maximum intensity projection of confocal z-stack of the DA at 48 hpf and 72 hpf (with or without 2.25x tricaine treatment) in WT and *eng^mu130^* mutants. *Tg(fli1a:lifeactEGFP)^mu240^* enrichment at cell-cell contacts, together with mosaic *Tg(-0.8flt1:RFP)^hu5333^* and *Tg(fli1a:nEGFP)^y7^,* can be used to outline 3D perimeters of cells. Note elongation and alignment of cells at 72 hpf compared to 48 hpf in WTs. *eng^mu130^* mutant cells have a larger surface area at 72 hpf, but tricaine treatment reduces surface area in both WTs and mutants. Scale bar is 25 um. **(d-g)** Quantification of DA endothelial cell shape parameters: cell elongation, angle, surface area and perimeter in WTs and *eng^mu130^* mutants. (48 hpf: n=38 cells from 2 WTs, n=35 cells from 2 muts; 72 hpf: n=27 cells from 2 WTs, n=33 cells from 2 muts; 72 hpf (2.25x tricaine): n=30 cells from 2 WTs, n=29 cells from 2 muts). Individual fish from 2 independent experiments per condition. See [Materials and Methods](#S8){ref-type="sec"} for description of statistical analysis. **(h)** Schematic of flow-induced EC shape changes. Flow causes WT cells to elongate and align without a change in their surface areas. In *eng^mu130^* mutants, elongation occurs normally, but EC sizes increase considerably.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, error bars indicate s.e.m.](emss-72239-f007){#F7}

![Role of endoglin in controlling morphology of mammalian ECs exposed to flow.\
**(a)** VE-cadherin (red) and nuclei (white) staining of HUVEC transfected with siRNAs against ENG or negative siRNA and exposed to unidirectional shear stress of 15 dyn/cm^2^ for 24 h. The arrow represents flow direction. Scale bar is 100 um. **(b)** Quantification of angle of nuclei to the direction of flow (set as 0°) in (**a**). The bars represent the mean nuclei angle (n=3 independent experiments). **(c)** Cell area, measured by dividing total image area by the number of nuclei. For all quantifications, an average was taken from five random images per sample (n=3 independent samples). Statistical analysis was performed with One-Way ANOVA and Tukey's multiple comparison test. **(d)** Immunostaining of ECs in thoracic aorta from WT and *Eng^flox/flox^:Cdh5(PAC)-CreER^T2^:R26Ryfp* mice at P9 after 50 ug tamoxifen injection at P4. GFP indicates recombination. EC outlines can be distinguished by CD31 labelling (red), and nuclei with ERG (blue). Scale bar is 20 um. **(e)** Quantification of surface area in ECs of the thoracic aorta in WT and *Eng* loss of function mice. (WT aorta: n=79 cells from 3 mice; *Eng* KO cells from fully recombined aorta: n=59 cells from 3 mice). Analysed by unpaired Student's *t*-test.\
n.s., not significant, \*P\<0.05, \*\*P\<0.01, error bars indicate s.e.m.](emss-72239-f008){#F8}
